Tag Archives: CTA

Clinical Trial Applications in Mexico: decentralization and acceleration of protocol approval

Posted on March 10, 2014 by Maria I. Guaia

With the goals of accelerating the development of new molecules that improve the healthcare and quality of life of Mexicans, and of stimulating clinical investigation, pharmaceutical innovation and foreign investment in the country, on the 5th of March 2014, the … Continue reading →